Novartis Gets Expert Testimony Blocked In Aredia-Zometa MDL

Law360, New York (December 17, 2012, 5:02 PM EST) -- A Tennessee federal judge on Thursday barred portions of expert testimony in cases stemming from multidistrict litigation against Novartis Pharmaceuticals Corp. over jaw damage blamed on osteoporosis drugs Aredia and Zometa, calling the witness unqualified to speak about links between the medications and bone loss.

U.S. Magistrate Judge C. Clifford Shirley Jr. partially granted a motion to exclude testimony after concluding that while Dr. Suzanne Parisian holds a medical degree, her career has been overwhelmingly focused on regulatory matters, not the actual practice of medicine. In...
To view the full article, register now.